BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang J, Chen S, Lin C. Targeting Cancer Stem Cells through Epigenetic Modulation of Interferon Response. JPM 2022;12:556. [DOI: 10.3390/jpm12040556] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Yan L, Ren B, Hu R, Zhang H, Gou H. Are PD-1 inhibitors effective for recurrent/metastatic nasopharyngeal carcinoma? Meta-analysis and systematic review. Front Pharmacol 2022;13:1095734. [PMID: 36699086 DOI: 10.3389/fphar.2022.1095734] [Reference Citation Analysis]
2 Cheon H, Wang Y, Wightman SM, Jackson MW, Stark GR. How cancer cells make and respond to interferon-I. Trends Cancer 2023;9:83-92. [PMID: 36216730 DOI: 10.1016/j.trecan.2022.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Cui G, Wang Z, Liu H, Pang Z. Cytokine-mediated crosstalk between cancer stem cells and their inflammatory niche from the colorectal precancerous adenoma stage to the cancerous stage: Mechanisms and clinical implications. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1057181] [Reference Citation Analysis]